Janiczek Wealth Management LLC Grows Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Janiczek Wealth Management LLC grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 4.7% during the first quarter, according to the company in its most recent filing with the SEC. The fund owned 1,814 shares of the healthcare conglomerate’s stock after acquiring an additional 82 shares during the quarter. Janiczek Wealth Management LLC’s holdings in UnitedHealth Group were worth $897,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in UNH. Texas Capital Bancshares Inc TX lifted its stake in shares of UnitedHealth Group by 1.1% in the third quarter. Texas Capital Bancshares Inc TX now owns 1,695 shares of the healthcare conglomerate’s stock worth $855,000 after acquiring an additional 19 shares in the last quarter. Tealwood Asset Management Inc. increased its holdings in UnitedHealth Group by 0.4% in the fourth quarter. Tealwood Asset Management Inc. now owns 4,988 shares of the healthcare conglomerate’s stock valued at $2,626,000 after buying an additional 19 shares during the last quarter. Atlas Private Wealth Advisors increased its holdings in UnitedHealth Group by 1.1% in the fourth quarter. Atlas Private Wealth Advisors now owns 1,752 shares of the healthcare conglomerate’s stock valued at $923,000 after buying an additional 19 shares during the last quarter. Prentice Wealth Management LLC increased its holdings in UnitedHealth Group by 0.8% in the fourth quarter. Prentice Wealth Management LLC now owns 2,347 shares of the healthcare conglomerate’s stock valued at $1,235,000 after buying an additional 19 shares during the last quarter. Finally, Baker Avenue Asset Management LP increased its holdings in UnitedHealth Group by 1.7% in the third quarter. Baker Avenue Asset Management LP now owns 1,219 shares of the healthcare conglomerate’s stock valued at $615,000 after buying an additional 20 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

UNH has been the subject of several research analyst reports. HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $580.00 price objective for the company in a report on Wednesday, June 5th. Royal Bank of Canada lowered their target price on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating for the company in a report on Wednesday, April 17th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $591.00 target price on shares of UnitedHealth Group in a report on Wednesday, June 12th. Erste Group Bank reaffirmed a “hold” rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. Finally, Baird R W raised UnitedHealth Group to a “strong-buy” rating in a report on Thursday, May 30th. Three equities research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus price target of $579.74.

UnitedHealth Group Stock Performance

UNH opened at $486.50 on Friday. The company has a market capitalization of $447.77 billion, a price-to-earnings ratio of 29.74, a price-to-earnings-growth ratio of 1.40 and a beta of 0.58. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $554.70. The business has a 50 day moving average price of $498.30 and a two-hundred day moving average price of $502.61.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The business had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. During the same period last year, the company posted $6.26 EPS. The company’s revenue was up 8.6% compared to the same quarter last year. Research analysts predict that UnitedHealth Group Incorporated will post 27.57 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Investors of record on Monday, June 17th were paid a $2.10 dividend. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.88. The ex-dividend date was Monday, June 17th. This represents a $8.40 dividend on an annualized basis and a yield of 1.73%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 51.34%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.